Should the use of omeprazole be allowed during equestrian competition?
Equine Veterinary Journal · 2025
DOI: 10.1111/evj.14129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Equine Veterinary Journal, 2025. Verfasst von Madeleine L H Campbell und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK. Hauptthemen laut MEDLINE: Omeprazole, Sports, Horse Diseases, Animal Welfare. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Horse Welfare.
Abstract (Originalsprache)
Background
Prioritising equine welfare, making evidenced‐based policy, and consistent decision‐making across sports are crucial to maintaining the social licence for equestrian sport. Regulations on the use of omeprazole during competition differ; all regulators argue that their rules prioritise welfare. This discrepancy is a matter of concern to the public and equestrian stakeholders.
Objectives
To apply Campbell's Ethical Framework for the use of Horses in Sport to the question: ‘Should the use of omeprazole be allowed during equestrian competition?’ Study design A desk‐based ethico‐legal study.
Methods
Campbell's Ethical Framework for the Use of Horses in Sport was applied in a stepwise fashion: definition of the ethical question; analysis of the evidence base; consideration of stakeholders' interests; harm:benefit analysis; application of the three central tenets of the framework, and formulation of conclusions and recommendations.
Results
Stakeholders in equine sports have a variety of (frequently conflicting) interests; all of them share an interest in optimising equine welfare. The incidence of EGUS in competition horses is high. Omeprazole is a cornerstone treatment. There are currently discrepancies in regulation about the use of omeprazole during competitions. Recent evidence suggests that withholding omeprazole treatment for two clear days before competition allows the recurrence of squamous EGUS, whereas withholding treatment on the day of competition only does not have that effect. Main limitations The current state of scientific knowledge about the use of omeprazole in horses. The analysis did not consider possible health and thus welfare effects of the out‐of‐competition treatment with omeprazole.
Conclusions
Based on recent scientific evidence, if horses are being treated with omeprazole outside of competition then treatment on the day of competition should be permitted on welfare grounds. Revision of regulations around the use of omeprazole during competition by governing bodies is necessary to safeguard the ethical use of horses in sport.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK.
- School of Veterinary Sciences, Massey University, Palmerston North, New Zealand.
ORCID-Profile: Madeleine L H Campbell, Benjamin W Sykes
Förderung
- World Horse Welfare
Zitieren
APA
Campbell, M. L. H., & Sykes, B. W. (2025). Should the use of omeprazole be allowed during equestrian competition?. Equine Veterinary Journal. https://doi.org/10.1111/evj.14129
Vancouver
Campbell MLH, Sykes BW. Should the use of omeprazole be allowed during equestrian competition?. Equine Veterinary Journal. 2025. doi:10.1111/evj.14129
BibTeX
@article{Campbell2025,
author = {Campbell, Madeleine L H and Sykes, Benjamin W},
title = {Should the use of omeprazole be allowed during equestrian competition?},
journal = {Equine Veterinary Journal},
year = {2025},
doi = {10.1111/evj.14129}
}
EUVIMED